Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Acorda Therapeutics, Inc. (NQ: ACOR)
34.84 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about Acorda Therapeutics, Inc.
 
< Previous 1 2 3 Next >
Technical Stock Breakout Watch: Acorda Therapeutics Inc (ACOR)
June 11, 2013
Bridgewater, MA -- (SBWIRE) -- 06/11/2013 -- The online StockConsultant latest screen has found a biotech company that provides drugs to improve neurological function for multiple sclerosis and spinal... Read More
from SBWire - Latest Press Releases
Acorda Therapeutics, Inc. (NASDAQ:ACOR), Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), and Exelixis, Inc. (NASDAQ:EXEL) Added to Equity Profile Report's NASDAQ Decliners Watch List.
May 03, 2013
Wilmington, DE -- (SBWIRE) -- 05/03/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Acorda Therapeutics, Inc. (NASDAQ:ACOR), Raptor Pharmaceuticals Corp.... Read More
from SBWire - Latest Press Releases
Investors Alert: UniPixel Inc, Gafisa SA, U.S. Bancorp, Acorda Therapeutics Inc
April 17, 2013
Lakeway, NY -- (SBWIRE) -- 04/17/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
NASDAQ Gainers Watch List: Athersys, Inc. (NASDAQ:ATHX), Acorda Therapeutics, Inc. (NASDAQ:ACOR), and Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) Added to Equity Profile Report's NASDAQ Gain
April 17, 2013
Wilmington, DE -- (SBWIRE) -- 04/17/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Athersys, Inc. (NASDAQ:ATHX), Acorda Therapeutics, Inc. (NASDAQ:ACOR), and Chelsea... Read More
from SBWire - Latest Press Releases
Stocks to Watch: Theravance, Sprint Nextel, Acorda Therapeutics, Athersys
April 16, 2013
Lakeway, NY -- (SBWIRE) -- 04/16/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
Week Ahead – Earnings Season is Here
April 15, 2013
category Market/Outlook , Week/Ahead , Market/Outlook/2013/Q2
from Wall Street Greek
NASDAQ Gainers Watch List: Acorda Therapeutics, Inc. (NASDAQ:ACOR) and Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 15, 2013
New York, NY -- (SBWIRE) -- 04/15/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Acorda Therapeutics, Inc. (NASDAQ:ACOR) and Lexicon Pharmaceuticals, Inc.... Read More
from SBWire - Latest Press Releases
NASDAQ MOST ACTIVES: Theravance, Inc., Acorda Therapeutics, Inc., Sinovac Biotech, Ltd., Life Technologies Corporation
April 15, 2013
Huntington Beach, CA -- (SBWIRE) -- 04/15/2013 -- PSPicks.com provides its subscribers with a free newsletter that reports up to the minute information and exclusive charts on cheap, undervalued,... Read More
from SBWire - Latest Press Releases
Stocks Review: Achillion Pharmaceuticals, Acorda Therapeutics Inc, Active Power, Adept Technology Inc
March 18, 2013
Lakeway, TX -- (SBWIRE) -- 03/18/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Most Active NASDAQ Stocks: Francesca's Holdings Corp, Acorda Therapeutics Inc, Merrimack Pharmaceuticals Inc, EZchip Semiconductor Ltd
March 06, 2013
Lakeway, TX -- (SBWIRE) -- 03/06/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
(ALKS) Alkermes Maintains Fiscal 2013 View
January 15, 2013
Alkermes plc (ALKS) recently reaffirmed its view for fiscal 2013 (ending March 31, 2013). The... Visit StockBlogHub to view complete post. Read More
category VRX , JNJ , ALKS , and 9 more.
from Stock Blog Hub
Flat Day All Around
January 03, 2013
The stock market indices had a strong start. They stair-stepped into midday, but when the S&P 500 made new highs early in the afternoon, the Nasdaq 100 could not and formed a head-and-shoulder... Read More
from Harry's Hotline by Harry Boxer
(ALKS) Back to Neutral on Alkermes
October 09, 2012
We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is... Visit StockBlogHub to view complete post. Read More
category ALKS , Johnson & Johnson , Novo Nordisk A/S , and 15 more.
from Stock Blog Hub
SPX & NDX Edge Higher in Mixed, Volatile Session
October 02, 2012
The stock market indices suffered early losses, and at one point late in the afternoon, after they bounced and started to get through the highs, they sold off very sharply in a 5-wave decline. By late... Read More
from Harry's Hotline by Harry Boxer
New Analyst Coverage
August 21, 2012
New York, August 21st (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate: Acorda Therapeutics (NA. Read More -- Read More
from TradersHuddle.com
What a Wall Street Week!
July 31, 2012
category Week/Ahead
from Wall Street Greek
Hot Option Plays: Tough One To Watch
June 21, 2012
Cusick’s Corner 06-21-2012 Defense is in play today but the rapid drop caught many traders off guard and by end of day had wiped out 38% of the rally off the June 4th lows. We could see an attempt to... Read More
category Options , FXI , SPY , and 10 more.
from DailyMarkets.com
Acorda Therapeutics Inc (NASDAQ:ACOR) Investor Alert: Investigation over Potential Violations of Securities Laws
June 13, 2012
San Diego, CA -- (SBWIRE) -- 06/13/2012 -- An investigation on behalf of investors of NASDAQ:ACOR shares over possible securities laws violations by Acorda Therapeutics Inc was announced and... Read More
from SBWire - Latest Press Releases
New Analyst Coverage: ACOR, BMY, CODE, MU, SNDK
May 18, 2012
New York, May 18th (TradersHuddle.com) - These are the research analyst new ratings before the market open. Acorda Therapeutics ( NASDAQ:ACOR ) was initiated with a Sell at Goldman Sachs. Br. Read More... Read More
from TradersHuddle.com
Biogen’s Fampyra Launched In Canada
April 13, 2012
Biogen Idec (NASDAQ:BIIB) recently announced the launch of Fampyra in Canada. Fampyra gained approval in Canada in February 2012 for the symptomatic improvement of walking ability in adult multiple... Read More
category TEVA , External Research , Contributor , and 8 more.
from DailyMarkets.com
Earnings Beat For Acorda
February 21, 2012
Acorda Therapeutics Inc.’s (NASDAQ:ACOR) fourth quarter earnings (including share-based compensation charges) of 32 cents per share were way above the Zacks Consensus Estimate of 17 cents and the... Read More
category ELN , WPI , Stocks , and 4 more.
from DailyMarkets.com
Up/Downgrades ( COP, FST, CMA, PNRA, ARW, AVT, ALTH, ACOR, AMGN, FST )
January 23, 2012
New York, January 23rd (TradersHuddle.com) - The following are top upgrades and downgrades before the market opens. ConocoPhillips ( NYSE:COP ) was downgraded to a Sell from Neutral at UBS. F. Read... Read More
from TradersHuddle.com
Small Cap Movers (MAKO, ACOR, OPEN, JNY, PWRD)
January 09, 2012
New York, January 9th (TradersHuddle.com) - MAKO Surgical Corp. ( NASDAQ: MAKO ) jumped 8.52% to $31.23 after the company reported fourth quarter 2011 and full year highlights. MAKO also anticipates... Read More
from TradersHuddle.com
Hot Option Plays: Range-Bound
January 05, 2012
Cusick’s Corner 01-05-2012 Yesterday I talked about range-bound consolidation and it happened again today. The market was challenged early to the downside, and then clawed its way back to end the day... Read More
category Options , HAS , orcl , and 9 more.
from DailyMarkets.com
Hot Option Plays: VIX Reflects Expectations Of Movement
December 15, 2011
Cusick’s Corner The VIX was right – not much was expected to happen. With the VIX at 25, the market was priced for nothing major to happen in spite of the minefield of headlines, data etc. So this is... Read More
category Options , BMC , APH , and 12 more.
from DailyMarkets.com
Ampyra Drives Acorda Revenues
November 09, 2011
Acorda Therapeutics Inc. (NASDAQ:ACOR) reported adjusted earnings of 40 cents per share for the third quarter of fiscal 2011, down from 43 cents in the year-ago period. After adjusting costs related to... Read More
category Stocks , External Research , Contributor
from DailyMarkets.com
(ACOR) Company News for October 6, 2011 – Corporate Summary
October 06, 2011
• Monsanto Co. (NYSE:MON) reported its fiscal fourth-quarter loss of $0.22 cents a share, better... Visit StockBlogHub to view complete post. Read More
category MON , Acuity Brands Inc/ , Yahoo! Inc/ , and 17 more.
from Stock Blog Hub
Stock Market News Briefs: Acorda Therapeutics, Acuity Brands Inc, Cbeyond, CBS, CTC Media, Lufkin Industries, Monsanto Company, Microsoft, Yahoo!
October 06, 2011
    Monsanto Co. (NYSE:MON) reported its fiscal fourth-quarter loss of $0.22 cents a share, better than the Zacks Consensus Estimate of a loss of $0.27. Revenues rose 15.1% year-over-year to $2.25... Read More
category yhoo , External Research , Contributor , and 9 more.
from DailyMarkets.com
Top biotech firms that have the potential to be taken over- ACOR, AMRN, DNDN, EXEL, HGSI, LXRX, VRTX 9/18/2011
September 18, 2011
Exelixis (EXEL), a biotechnology company committed to developing small molecule therapies for the treatment of cancer, GlaxoSmithKline, Genentech/Roche, Sanofi, Bristol Myers-Squibb, and... Read More
category EXEL , Healthcare Pharmaceuticals Stock Market , DNDN , and 5 more.
from CEOWORLD Magazine
Unfavorable Ruling For Acorda
September 12, 2011
Acorda Therapeutics, Inc. (NASDAQ:ACOR) recently received an unfavorable court ruling in its patent litigation case against Apotex. Apotex had filed an abbreviated new drug application (ANDA) with the... Read More
category Stocks , External Research , Contributor , and 2 more.
from DailyMarkets.com
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here